Jan 11, 2022 / 03:30PM GMT
Richard Vosser - JPMorgan Chase & Co, Research Division - Senior Analyst
(technical difficulty) Health Care Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. It's my great pleasure to introduce from Sanofi, the CEO, Paul Hudson. (Operator Instructions) With that, Paul, welcome to the conference. Good to see you
Paul Hudson - Sanofi - CEO & Director
Thanks, Richard. Thank you very much. Delighted to be here. Sadly, virtually, but very happy to share the progress we're making as a company and going to get into the detail.
JB, Jean-Baptiste, and I will take you through the upfront and the business and finance, of course. And then we'll be joined by other members of the executive team for the Q&A. So maybe we go to the next slide.
So for me, at least, it's just over two years since we had a Capital Markets Day 2019. It's pretty staggering, the progress we've made. If you'd have asked me whether I thought we'd have made this much progress two years later, I would have said, "I hope so, but I'm not sure because we don
Sanofi SA at JPMorgan Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers